
⸺ Synova Research
Selank supplied as a ready-to-use nasal spray solution, ≥99% purity. Intranasal presentation for anxiolytic-pathway research.
Secure checkout via UK open banking. Free shipping on orders over £100.
Independently tested
COA on request
Next-day UK dispatch
Order before midnight
Research use only
Not for human consumption
⸺ Important
⸺ Overview
Selank is a synthetic analogue of the immunomodulatory peptide tuftsin, supplied here as a pre-mixed nasal spray. It is used in preclinical research into stress-response, anxiety-related behaviour and immune signalling.
⸺ Mechanism of Action
Selank is studied for its modulation of GABAergic and monoaminergic signalling alongside effects on interleukin expression, pathways linked to anxiety-related behaviour in animal models.
⸺ Research
Rodent studies examine behavioural markers of stress and anxiety following Selank administration.
Research investigates changes in cytokine and interleukin expression.
Preclinical work explores memory and attention alongside anxiolytic endpoints.
Summarised from preclinical literature for informational purposes only. Not medical or veterinary advice. Synova Research products are sold strictly for in-vitro and laboratory research.
⸺ Details

Investigational triple receptor agonist targeting GLP-1, GIP and glucagon — studied in animal models for appetite control, energy expenditure and glucose balance.

Dual GLP-1 and GIP receptor agonist studied in preclinical models for glucose regulation, insulin sensitivity and energy balance.

Synthetic analogue of the GLP-1 hormone used in research to study glucose regulation, insulin secretion and the incretin response.